Archivi Categorie: Health Technology Assessment

Su tasse e spending review la tabella (allegata) dell’Economist vale mille parole

Andrea Tavecchio – 26 maggio 2012 Taglio o meno delle spese e delle tasse saranno il tema della prossima campagna elettorale, come in fondo quello di tutte le campagne elettorali degli ultimi vent’anni. Professor Monti a che punto è il lavoro di Amato, Bondi e Giavazzi sulla revisione della spesa e dei sussidi per partiti, sindacati, imprese e [...]

Don Berwick on healthcare spending: “We have to improve our way out of this”

Don Berwick ritiene che, in USA, un terzo della spesa sia “sprecato”! E in Italia? Cost figures from the healthcare reform debate are large enough to defy comprehension, but Dr. Donald Berwick boils things down to one crucial figure: $1 out of every $3 spent on healthcare is wasted. He then argues that the way [...]

La frode scientifica: il lato oscuro della ricerca

Cristiano Alicino e Alice Fabbri in http://saluteinternazionale.info/ Fintanto che la ricerca rimarrà strumentale al perseguimento di obiettivi personali e commerciali, spesso convergenti, la frode scientifica rappresenterà un ineluttabile effetto collaterale del sistema. “Una letteratura attendibile ha la capacità di trasformare l’autore tanto quanto il lettore” -  mentre  – “la frode nell’ambito della ricerca scientifica può danneggiare [...]

Innovation in research methods and dissemination – ensuring best practice @bmj_latest

The Association of the British Pharmaceutical Industry (ABPI) and BMJ Group held a joint conference at BMA House yesterday entitled ‘Innovation in research methods and dissemination – ensuring best practice’. The event brought in some big names, including our very own Dr. Fiona Godlee (Editor-in-chief, BMJ), Professor Sir Alasdair Breckenridge (Chairman, Medicines and Healthcare products [...]

In health care, cheaper can mean better

DR. DONALD M. BERWICK nel Boston Globe http://b.globe.com/KpLt5g  An Irish adage says: “When you come to a wall that is too high to climb, throw your hat over the wall, and then go get your hat.” That’s what Massachusetts started with its 2006 law requiring just about everyone to get coverage and arranging to make that coverage [...]

Health Act makes NICE stronger than ever before

NICE will be stronger than ever before under the new Health Act producing quality standards that will be the backbone of commissioning and playing a vital role in value based pricing, the Health Secretary has said. Addressing delegates at the NICE Annual Conference in Birmingham yesterday, Andrew Lansley said that NICE will be central to [...]

Finanziamento di organizzazioni dei pazienti dall’industria farmaceutica. Un’indagine in Italia

Cinzia Colombo1*, Paola Mosconi1, Walter Villani1, Silvio Garattini2 hanno condotto un’indagine per verificare se la dichiarazione sul conflitto d’interesse sia chiara, completa e accessibile al pubblico. http://www.slideshare.net/carlofavaretti/patient-organizations-funding Background: Many patients’ and consumers’ organizations accept drug industry funding to support their activities. As drug companies and patient groups move closer, disclosure become essential for transparency, and [...]

XVII Convegno Nazionale AIES – Call For Abstract

Annuncio del XVII Convegno Nazionale dell’ Associazione Italiana di Economia Sanitaria (AIES) dal titolo “RIFORME IN SANITA’ IMPATTO E PROSPETTIVE PER IL SISTEMA E LE AZIENDE”. Il Convegno è organizzato dalla Facoltà di Economia dell’Università Cattolica del Sacro Cuore in collaborazione con l’Alta Scuola in Economia e Management dei Servizi Sanitari (ALTEMS) e il Centro [...]

Choosing Wisely: How to avoid unnecessary tests and treatments

Think you need an EKG as part of your annual exam? Think again. How about an MRI or CT scan for your headache? Probably not. And antibiotics for that case of sinusitis that has been bugging you? Sorry, that’s strike three. Many common tests and treatments are often overused, both because patients too often ask [...]

Avastin versus Lucentis: il punto sul BMJ del 2 maggio 2012

Editoriale di Fiona Godlee seguito da tre articoli che presentano in modo articolato, ma chiarissimo, il tema del trattamento della maculopatia degenerativa. http://www.slideshare.net/carlofavaretti/lucentis-fiona-godlee I fattori di crescita endoteliale anti-vascolari preservano e fanno recuperare la vista a milioni di persone nel mondo. http://www.slideshare.net/carlofavaretti/endotelial-growth Lucentis è registrato per il trattamento; Avastin no. Il primo costa 12 volte il secondo [...]

Patients want to use social media tools to manage health care

By PAMELA LEWIS DOLAN, amednews staff. http://www.ama-assn.org/amednews/ Some patients have moved beyond wanting social media content they can “follow” or “like.” They want social media to be something that helps them coordinate care and navigate the health care system, and they think physicians are the best people to deliver it. A survey of 1,060 U.S. adults by the [...]

Patients choose hospitals based on social media

With one-third of consumers using social media for seeking or sharing medical information, 41 percent say tools like Facebook, Twitter, YouTube and online forums influence their choice of a specific hospital, medical facility or doctor, according to Tuesday’s report from consulting firm PwC. In a survey of more than a thousand consumers, more than two-fifths of individuals [...]

Essential health benefits in USA, Livelli essenziali di assistenza in Italia

Anche negli USA, la riforma Obama prevede LEA definiti a livello di singoli Stati e non uno standard nazionale, pur assicurando che gli essential health benefits coprano 10 categorie, incluse l’assistenza ospedaliera, quella materno-infantile, ambulatoriale e farmaceutica. Health Affairs pubblica un Health Policy Brief sul tema: http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief_id=68

Richard Smith: Disclosure of conflicts of interest may increase bias @Richard56

I’ve worried that disclosing conflicts of interest may be counterproductive ever since we did an experiment that showed that readers of articles with declared conflicts discounted not only the believability of the results, but every aspect of the paper, including its importance and originality.  Now my worries areincreased by a paper in JAMA and an editorial in PloS Medicine providing [...]

Le tecnologie sanitarie nel SSN @unibocconi

Spesa, volumi e politiche sanitarie in discussione a Milano il 16 maggio 2012. Convegno organizzato dal CERGAS in collaborazione con la Direzione Generale dei Farmaci e Dispositivi Medici del Ministero della Salute. http://bit.ly/K6G0Uj

Iscriviti

Get every new post delivered to your Inbox.

Join 343 other followers